Poultry Healthcare Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 8.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Poultry Healthcare Market Analysis
The poultry healthcare market is expected to witness a CAGR of 8.5% during the forecast period.
COVID-19 has affected the poultry healthcare market significantly. The supply chain was disrupted due to the restriction imposed worldwide, leading to difficulties in moving animal products, such as meat, milk, and eggs, to markets during the initial period. For instance, according to an article published by MDPI, in March 2022, COVID-19 severely impacted the poultry production sector. The impact was more severe in developing countries due to the dependency on exporting necessary supplies such as feed, vaccines, and drugs. Thus, trade limitations led to the economic crisis, which adversely impacted poultry industries, including the agricultural value chain, such as the livestock production sector. However, with the declining COVID-19 cases, there has been an increase in trade and agricultural production, leading to proper care and nutrition for the chickens, eventually rising the demand for poultry healthcare, thereby driving the growth of the market over the forecast period.
Factors that are propelling the market growth are the increasing initiatives by government and animal welfare associations, the rising occurrence of zoonotic diseases, and the rise in demand for poultry-derived food products. The number of zoonotic disease cases in poultry animals has risen significantly in recent years. For instance, according to WHO update in December 2022, globally, till November 2022, there have been 868 cases of human infection with avian influenza A(H5N1) virus reported from 21 countries and as of December 2022, a total of 240 cases of human infection with avian influenza A(H5N1) virus have been reported from four countries within the Western Pacific Region. Thus, the rising occurrence of avian influenza is expected to increase the risk of spreading the virus to humans, which in turn is anticipated to increase the demand for effective diagnostic and therapeutics to prevent the impact of the virus in birds, thereby fueling the market growth.
Additionally, an article published by Frontiers Media S.A. in November 2021, reported that both commercial broilers and layers tested positive for Newcastle disease virus (NDV) using the M gene rRT-PCR. In addition, as per the same source, based on M gene identification, flocks with mild respiratory issues had a greater prevalence of Newcastle disease virus (15.7%), followed by healthy (9.1%) and sick (3.0%) flocks, in India. Thus, the high prevalence of Newcastle disease in poultry birds is expected to increase the demand for early detection and treatment of the disease to avoid its transmission to humans, which in turn is anticipated to propel the market growth over the forecast period.
Furthermore, the rising company activities in developing products and increasing product launches also contribute to the market growth. For instance, in October 2021, Cargill launched poultry feed with essential oils, Nutrena Naturewise, for healthy flocks and maximized egg production. The improved Nutrena NatureWise formulas help in boosting the overall wellness, happiness, and productivity of backyard chickens. Also, in October 2020, the company Boehringer Ingelheim Animal Health launched the VAXXITEK HVT+IBD+ILT vaccine against Laryngotracheitis, Marek's Disease, and Infectious Bursal Disease.
However, the use of counterfeit medicines and lack of veterinarians, and a shortage of skilled farm workers are likely to impede the market growth over the forecast period.
Poultry Healthcare Market Trends
This section covers the major market trends shaping the Poultry Health Market according to our research experts:
The Vaccines Segment is Expected to Show Better Growth Over the Forecast Period
The vaccine segment is expected to witness significant growth in the poultry healthcare market over the forecast period owing to increased chicken meat production, the rising prevalence of zoonotic diseases, and increased investment in vaccine development by key players to prevent zoonotic diseases. For instance, according to the United States Department of Agriculture, Foreign Agricultural Service, January 2023 report, with upward improvements for the United Kingdom, Thailand, and Mexico, global chicken meat production for 2023 is estimated to be 102.9 million tons. Similarly, global chicken meat exports for 2023 were estimated to be 14.0 million tons. With the increasing chicken meat production, the need to opt for preventive vaccines to prevent diseases in poultry also increases, which is expected to help the segmental growth over the forecast period.
In addition, the rising company activities in developing vaccines for preventing poultry animals from infections and diseases are also contributing to the market growth. For instance, in January 2021, Zoetis launched the Poulvac Procerta HVT-IBD vaccine for the protection of poultry against Infectious Bursal Disease (IBD). Also, in May 2021, Elanco Health Incorporated signed four contracts with EVAH Corp. to acquire and develop technologies in animal health. The four contracts between EVAH and Elanco relate to four products in development (two feed additives and two vaccines) targeting three species: salmon, swine, and poultry.
North America Shows a Significant Market Growth Over the Forecast Period
North America is expected to dominate the global poultry healthcare market over the forecast period, owing to factors such as the rising demand for poultry-derived food products and the rising occurrence of zoonotic diseases in the region. For instance, according to the United States Department of Agriculture, Foreign Agricultural Service, January 2023 report, chicken meat production in the United States increased from 20,391 in 2021 to 20,845 in 2022, and chicken meat production in Mexico increased from 3,815 in 2021 to 3,900 in 2022. With the increasing poultry production, the number of poultry affected by diseases is also expected to increase. To counter this, the farmers are expected to opt for poultry healthcare, driving market growth over the forecast period.
Additionally, per an article published by the Association of Food and Drug Officials in January 2022, the avian influenza virus has found its way to Canada's Atlantic coast in the Province of Newfoundland and Labrador. Maine has the potential to be the next hotspot for this avian influenza if certain preventative measures are not taken immediately. To stop the spread of the disease and prevent poultry from infections, veterinarians suggest healthcare measures. This is expected to increase the market growth over the forecast period.
Furthermore, the rising product launches in the region are expected to boost the market growth. For instance, in August 2021, Huvepharma Canada Corporation Inc. launched a new vaccine, Clostridium Perfringens Type A, a live vaccine, in Canada. The vaccine can be administered to broiler chickens at the day of age or older for necrotic enteritis (NE) due to Clostridium perfringens type A in broiler chickens. Also, in January 2020, Boehringer Ingelheim's United States Animal Health Business launched a vaccine, VAXXITEK HVT+IBD+ND, to protect poultry from three diseases, in India. It provides a strong immune foundation and optimized protection against Marek's Disease, Infectious Bursal Disease (classic and variant types), and Newcastle Disease.
Poultry Healthcare Industry Overview
The poultry healthcare market is moderately concentrated in nature due to the presence of companies operating globally as well as regionally, including Elanco, Boehringer Ingelheim GmbH, Ceva Sante Animale, Merck & Co. Inc., IDEXX Laboratories, Inc., Megacorp Diagnostik GmbH, Thermo Fisher Scientific Inc., Virbac, and Zoetis Inc.
Poultry Healthcare Market Leaders
Boehringer Ingelheim GmbH
Ceva Santé Animale
IDEXX Laboratories, Inc.
Zoetis Inc.
Elanco
*Disclaimer: Major Players sorted in no particular order
Poultry Healthcare Market News
- In May 2022, Canada invested over USD 3 million in two projects to enhance emergency management and develop risk assessments and strategies to mitigate disease outbreaks. This project will help enhance the emergency management capabilities of Canada's livestock and poultry industries to remain ready in the face of adverse events and a continually evolving disease landscape.
- In April 2022, Ceva Animal Health launched CEVAC IBird, a live attenuated freeze-dried vaccine, for the active immunization of chickens against the variant strain of avian infectious bronchitis virus, containing strain 1/96, in India.
Poultry Healthcare Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Initiatives by Government and Animal Welfare Associations
4.2.2 Rising Occurrence of Zoonotic Diseases
4.2.3 Rise in Demand for Poultry-derived Food Products
4.3 Market Restraints
4.3.1 Use of Counterfeit Medicines
4.3.2 Lack of Veterinarians and Shortage of Skilled Farm Workers
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Product Type
5.1.1 Vaccines
5.1.2 Parasiticides
5.1.3 Anti Infectives
5.1.4 Medical Feed Additives
5.1.5 Other Product Types
5.2 By Test Type
5.2.1 ELISA (Enzyme-Linked Immunosorbent Assay) Test
5.2.2 PCR (Polymerase Chain Reaction) Test
5.2.3 Molecular Diagnostic Test
5.2.4 Other Test Types
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Thermo Fisher Scientific Inc.
6.1.2 Boehringer Ingelheim GmbH
6.1.3 Ceva Sante Animale
6.1.4 Merck & Co. Inc.
6.1.5 IDEXX Laboratories, Inc.
6.1.6 Megacor Diagnostik GmbH
6.1.7 Elanco
6.1.8 Zoetis Inc.
6.1.9 Hester Biosciences Limited
6.1.10 Indovax
6.1.11 Provet Pharma Private Limited
6.1.12 Bimeda, Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Poultry Healthcare Industry Segmentation
As per the scope of the report, poultry animals are domesticated birds, including ducks, chickens, turkeys, geese, quails, and other birds kept by humans. The poultry industry is one of the fastest-growing segments of livestock animals. The scope of the report emphasizes the importance of poultry animal care, for which the veterinarian is the pivotal link for the companies for the continual improvements in poultry animal health and welfare.
The Poultry Healthcare Market is segmented by Product Type (Vaccines, Parasiticides, Anti-Infectives, Medical Feed Additives, and Others), Test Type (ELISA (Enzyme-Linked Immunosorbent Assay) Test, PCR (Polymerase Chain Reaction) Test, Molecular Diagnostic Test, and Other Test Types), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Product Type | |
| Vaccines | |
| Parasiticides | |
| Anti Infectives | |
| Medical Feed Additives | |
| Other Product Types |
| By Test Type | |
| ELISA (Enzyme-Linked Immunosorbent Assay) Test | |
| PCR (Polymerase Chain Reaction) Test | |
| Molecular Diagnostic Test | |
| Other Test Types |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Poultry Healthcare Market Research FAQs
What is the current Global Poultry Healthcare Market size?
The Global Poultry Healthcare Market is projected to register a CAGR of 8.5% during the forecast period (2024-2029)
Who are the key players in Global Poultry Healthcare Market?
Boehringer Ingelheim GmbH, Ceva Santé Animale, IDEXX Laboratories, Inc., Zoetis Inc. and Elanco are the major companies operating in the Global Poultry Healthcare Market.
Which is the fastest growing region in Global Poultry Healthcare Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Poultry Healthcare Market?
In 2024, the North America accounts for the largest market share in Global Poultry Healthcare Market.
What years does this Global Poultry Healthcare Market cover?
The report covers the Global Poultry Healthcare Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Poultry Healthcare Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Poultry Health Industry Report
Statistics for the 2024 Poultry Health market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Poultry Health analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
